| Code | 0113F | ||||||||||
| MA number | 27/0193/25-S | ||||||||||
| Product Form: | tbl 100x25 mg/250 mg (fľ.HDPE) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Orion Corporation, Finland | ||||||||||
| Therapeutic Class: | 27 - ANTIPARKINSONICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | bottle HDPE | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 29.05.2025 |
| Validity: | 29.05.2030 |
| SPC: |
SPC_CARLEVO 25 mg_250 mg_05 2025.pdf
|
| PIL: |
PIL_CARLEVO 25 mg_250 mg_05 2025.pdf
|
| Safety feature | Yes |
| Data update: | 29.05.2025 |
